IMPROVING ONCOLOGY ANALYSIS WITH INTEGRATED KRAS ASSAY COMPANIES AND RAS ASSAYS

inside the quickly evolving discipline of oncology research, correct and successful mutation screening is critical for establishing focused therapies. The KRAS expert services Platform plays a pivotal function On this landscape by presenting in depth solutions for KRAS mutation profiling and Evaluation. KRAS mutations, present in about 95% of RAS-c